These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14270530)

  • 1. URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
    BOZZI R; BRUNO A; ALLEGRANZA A
    Br J Psychiatry; 1965 Feb; 111():176-82. PubMed ID: 14270530
    [No Abstract]   [Full Text] [Related]  

  • 2. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 3. [URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID, HOMOVANILLIC AND VANILLYLMANDELIC ACIDS IN SCHIZOPHRENIC SUBJECTS WITH RESERPINE AND CHLORPROMAZINE].
    ALLEGRANZA A; BOZZI R; BRUNO A
    Riv Patol Nerv Ment; 1963 Jun; 84():181-200. PubMed ID: 14088041
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF RESERPINE, CHLORPROMAZINE AND HALOPERIDOL ON THE MONOAMINES IN CENTRAL NERVOUS SYSTEM.
    Roos BE
    Acta Psychiatr Scand; 1964; 39(S180):421-2. PubMed ID: 14345228
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICAL AND ELECTROMYOGRAPHIC ANALYSIS OF MOTOR DISORDERS IN NEUROLEPTIC THERAPY].
    ZAKRZEWSKA F
    Neurol Neurochir Psychiatr Pol; 1963; 13():679-86. PubMed ID: 14091516
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDIES OF THE URINARY 5-HYDROXYINDOLEACETIC ACID WITH SPECIAL REFERENCE TO CASES WITH THYROID DISORDERS].
    CHIBA N
    Tohoku Igaku Zasshi; 1963 May; 67():543-61. PubMed ID: 14159772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies].
    BOURGUIGNON A; DELAY J; DENIKER P; LEMPERIERE T
    Encephale; 1956; 45(4):1093-8. PubMed ID: 13384344
    [No Abstract]   [Full Text] [Related]  

  • 8. SYKES TF: EXTRAPYRAMIDAL SIDE EFFECTS AND THERAPEUTIC RESPONSE.
    BISHOP MP; GALLANT DM
    Arch Gen Psychiatry; 1965 Aug; 13():155-62. PubMed ID: 14314761
    [No Abstract]   [Full Text] [Related]  

  • 9. [Extrapyramidal syndromes induced by chlorpromazine and reserpine].
    BOURGUIGNON A
    Sem Hop Ther Paris; 1960 Jul; 36():632-3. PubMed ID: 13803333
    [No Abstract]   [Full Text] [Related]  

  • 10. NON-POLAR URINARY METABOLITES OF CHLORPROMAZINE IN MALE SCHIZOPHRENICS.
    ROSE RM; DIMASCIO A; KLERMAN GL
    J Psychiatr Res; 1964 Dec; 2():299-305. PubMed ID: 14271968
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES OF PERIODIC CATATONIA. II. THE URINARY EXCRETION OF PHENOLIC AMINES AND ACIDS WITH AND WITHOUT LOADS OF DIFFERENT DRUGS.
    GJESSING LR
    J Psychiatr Res; 1964 Oct; 2():149-62. PubMed ID: 14242373
    [No Abstract]   [Full Text] [Related]  

  • 12. URINARY EXCRETION OF PHENOLIC ACIDS IN HUMAN SUBJECTS ON A GLUCOSE DIET.
    VONSTUDNITZ W; ENGELMAN K; SJOERDSMA A
    Clin Chim Acta; 1964 Mar; 9():224-7. PubMed ID: 14152336
    [No Abstract]   [Full Text] [Related]  

  • 13. RESERPINE TOLERANCE TEST IN SCHIZOPHRENIC SUBJECTS.
    BRUNO A; ALLERGRANZA A; BOZZI R
    J Nerv Ment Dis; 1964 Sep; 139():241-6. PubMed ID: 14212176
    [No Abstract]   [Full Text] [Related]  

  • 14. ETHANOL AND URINARY CATECHOLAMINES IN MAN.
    ANTON AH
    Clin Pharmacol Ther; 1965; 6():462-9. PubMed ID: 14314969
    [No Abstract]   [Full Text] [Related]  

  • 15. [5-Hydroxyindoleacetic acid excretion in urine of schizophrenics with reference to effects of chlorpromazine and reserpine on serotonin metabolism].
    SANO I; KAKIMOTO Y; OKAMOTO T; NAKAJIMA H; KUDO Y
    Schweiz Med Wochenschr; 1957 Mar; 87(9):214-7. PubMed ID: 13432651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extrapyramidal syndrome in chlorpromazine and serpasil therapy; clinical symptomatology and therapeutic role].
    STECK H
    Encephale; 1956; 45(4):1083-9. PubMed ID: 13384342
    [No Abstract]   [Full Text] [Related]  

  • 17. [COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
    HAEFNER H; KUTSCHER I
    Arztl Forsch; 1964 Jan; 18():18-36. PubMed ID: 14140626
    [No Abstract]   [Full Text] [Related]  

  • 18. ASYPHYXIA RELATIVELY INHERENT TO TRANQUILIZATION. REVIEW OF THE LITERATURE AND REPORT OF SEVEN CASES.
    PLACHTA A
    Arch Gen Psychiatry; 1965 Feb; 12():152-8. PubMed ID: 14237625
    [No Abstract]   [Full Text] [Related]  

  • 19. DECREASE OF 5-HYDROXYINDOLEACETIC ACID (5-HIAA) EXCRETION IN OLD AGE.
    FOELDES I; CSOETOERTOEK L; BEREGI E
    Gerontol Clin (Basel); 1965; 7():92-5. PubMed ID: 14296128
    [No Abstract]   [Full Text] [Related]  

  • 20. [On several complications of neuroleptic treatment].
    SCHNEIDER G
    Schweiz Arch Neurol Neurochir Psychiatr; 1959; 84():329-37. PubMed ID: 14443222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.